Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/35360
Title: | Can resting lung function predict the response of a person living with motor neuron disease to a hypoxic challenge test? | Austin Authors: | Clohessy, Talia;Sheers, Nicole ;Berlowitz, David J ;Ruehland, Warren R ;Brazzale, Danny | Affiliation: | Respiratory and Sleep Medicine (Austin Health) Physiotherapy (Austin Health) Institute of Breathing and Sleep |
Issue Date: | Aug-2024 | Abstract: | Aim People living with MND (PlwMND) are at risk of altitude-related hypoxia during flight. The Hypoxic Challenge Test (HCT) determines whether in-flight oxygen is required but can be expensive and inaccessible. To assist with travel recommendations, we investigated the relationship between altitude simulation-induced hypoxaemia and baseline lung function, a routinely performed test in this population. Methods Retrospective audit of clinical database of PlwMND who had HCT and lung function. Pearson’s correlation assessed relationships between oxygen saturation at altitude (AltSpO2) and lung function. Univariate logistic regression analysis and receiver operator characteristic (ROC) curves determined associations between lung function and HCT pass or fail. Results Between 2004-2023, 50 PlwMND were identified (median (IQR) diagnosis to HCT = 11.6 (16.9) months, mean ± SD forced vital capacity (FVC) = 2.4 ± 0.9 litres). Ten patients dropped below 85% SpO2 during testing (HCT fail). Baseline SpO2 was associated with AltSpO2 (r=0.64) and predicted HCT pass or fail (OR 2.0 [95% CI 1.2-3.4], area under ROC curve (AUC) =0.8 [0.6-1.0]), as did FVC (AUC = 0.8 [0.6-0.9]). PlwMND with a FVC >2.7L or a resting SpO2 >97% are likely to pass HCT, whereas all those with FVC <1L and SpO2 < 92% failed. Conclusion PlwMND with FVC >2.7L or SpO2 >97% are unlikely to require oxygen or ventilatory supports for airline travel. An FVC below 2.7L will require a HCT to confidently determine HCT outcome, with testing still required for FVC <1L or baseline SpO2 <92%, to provide evidence to the airlines for in-flight respiratory support. Impact These data support the consensus based British Thoracic Society guidelines around when HCT testing is needed prior to air travel for patients with respiratory disease. Common spirometry and pulse oximetry thresholds may help guide clinicians and people living with MND to make meaningful and safe choices around travel. | Description: | ResearchFest 2024 | Conference Name: | ResearchFest 2024 | Conference Location: | Austin Health | URI: | https://ahro.austin.org.au/austinjspui/handle/1/35360 | ORCID: | 0009-0009-8638-8109 0000-0003-1847-4266 0000-0003-2543-8722 0000-0001-9626-7460 0009-0007-5148-2969 |
Type: | Conference Presentation | Subjects: | Motor neuron disease Hypoxic challenge testing Fitness to fly Respiratory function testing |
Appears in Collections: | ResearchFest abstracts |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ResearchFest Poster_online.pdf | Can resting lung function predict the response of a person living with motor neuron disease to a hypoxic challenge test? | 403.83 kB | Adobe PDF | ![]() View/Open |
Page view(s)
42
checked on Aug 24, 2024
Download(s)
14
checked on Aug 24, 2024
Google ScholarTM
Check
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.